Publications

Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, Djauzi S, Iqbal Z, Karim HM, Naeem SM, Tantawichien T, Zotomayor R, Patil S, Schmitt HJ. The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion. Travel Medicine and Infectious Disease 2013;11:288-94. [Abstract]

Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR, the Serotype Replacement Study Group (including McIntyre P, Menzies R, Jayasinghe S) . Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Medicine 2013;10:e1001517. [Abstract]

Rashid H, Barasheed O, Booy R. Acute febrile respiratory infection symptoms in Australian Hajjis at risk of exposure to Middle East respiratory syndrome coronavirus [letter] . Medical Journal of Australia 2013;199:453 . [Abstract]

Rashid H, Barasheed O, Booy R. Acute febrile respiratory infection symptoms in Australian Hajjis at risk of exposure to Middle East respiratory syndrome coronavirus [letter] . Medical Journal of Australia 2013;199:453. [Abstract]

Mahajan D, Cook J, Dey A, Macartney K, Menzies R. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012. Communicable Diseases Intelligence 2013;37:E130-4. [Full text]

Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH. Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents . Influenza and Other Respiratory Viruses 2013;7:676-85. [Abstract]

Hull B. Australian childhood immunisation coverage, 1 October to 31 December cohort, assessed as at 31 March 2013 [quarterly report]. Communicable Diseases Intelligence 2013;37:E276-7 . [Full text]

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Garman P, Gutierrez Gimeno MV, Heijbel H, Hur K, Hviid A, Kelman J, Kilpi T, Lau KW, Chuang SK, Mac. International collaboration to assess the risk of Guillain Barré syndrome following influenza A (H1N1) 2009 monovalent vaccines. Vaccine 2013;31:4448-58. [Abstract]

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Garman P, Gimeno MV, Heijbel H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, . International collaboration to assess the risk of Guillain Barré syndrome following influenza A (H1N1) 2009 monovalent vaccines. Vaccine 2013;31:4448-58 . [Abstract]

O’Grady KF, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, Van Asperen P, Richmond P, Thornton R, Rablin S, Chang AB. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials 2013;14:282. [Abstract]